Results 141 to 150 of about 24,706 (195)
Imaging in Juvenile Idiopathic Arthritis: A Comprehensive Review. [PDF]
Chandola S, Bagri N, Jana M.
europepmc +1 more source
Osteopathia striata with cranial sclerosis, associated with juvenile idiopathic arthritis: A case report and review of literature. [PDF]
Yakovlev AA +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Clinics of North America, 2012
Juvenile idiopathic arthritis (JIA) encompasses a complex group of disorders with arthritis as a common feature. This article provides the pediatrician with a review of the epidemiology, classification, clinical manifestations, and complications of JIA.
Shirley M L Tse
exaly +5 more sources
Juvenile idiopathic arthritis (JIA) encompasses a complex group of disorders with arthritis as a common feature. This article provides the pediatrician with a review of the epidemiology, classification, clinical manifestations, and complications of JIA.
Shirley M L Tse
exaly +5 more sources
Systemic Juvenile Idiopathic Arthritis
Pediatric Clinics of North America, 2018Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of juvenile idiopathic arthritis, characterized by fever and arthritis, often accompanied by rash, sometimes by generalized lymphadenopathy, hepatosplenomegaly, and serositis. The diagnosis requires adequate exclusion of infectious, oncologic, autoimmune, and autoinflammatory ...
Jennifer J Y Lee, Rayfel Schneider
exaly +3 more sources
Pediatrics in Review, 2023
Juvenile idiopathic arthritis (JIA) comprises a group of heterogenous disorders characterized by childhood-onset chronic joint inflammation. It is the most common rheumatologic disease in the pediatric population and an important cause of chronic illness in children.
Andrew M, Long, Bethany, Marston
openaire +2 more sources
Juvenile idiopathic arthritis (JIA) comprises a group of heterogenous disorders characterized by childhood-onset chronic joint inflammation. It is the most common rheumatologic disease in the pediatric population and an important cause of chronic illness in children.
Andrew M, Long, Bethany, Marston
openaire +2 more sources
The Lancet, 2007
Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Autoimmunity Reviews, 2006
One of the most enigmatic problems in rheumatology has been juvenile idiopathic arthritis (JIA). Firstly, the classification has often depended on clinical features that have variations between patients. Secondly, there are different classification schemes in usage and there are few objective serologic tests that help to resolve the differences between
A. T. Borchers +5 more
openaire +2 more sources
One of the most enigmatic problems in rheumatology has been juvenile idiopathic arthritis (JIA). Firstly, the classification has often depended on clinical features that have variations between patients. Secondly, there are different classification schemes in usage and there are few objective serologic tests that help to resolve the differences between
A. T. Borchers +5 more
openaire +2 more sources
Pharmacosurveillance in Juvenile Idiopathic Arthritis
Rheumatic Disease Clinics of North America, 2021The advent of biologic disease-modifying antirheumatic drugs targeting specific cytokines or cell-cell interactions has dramatically changed the outlook of patients with juvenile idiopathic arthritis. However, safety concerns remain around the use of therapeutic agents for children with juvenile idiopathic arthritis.
Natalie J, Shiff, Timothy, Beukelman
openaire +2 more sources
Nederlands Tijdschrift voor Tandheelkunde, 2018
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammation of the joints in childhood. Currently, JIA is divided into 7 subtypes, distinguished on the basis of the symptoms present in the first six months of the illness. Pharmacological treatment is different for every subtype. With all forms of JIA, dental problems can occur.
Schatorjé, E.J., Royen-Kerkhof, A. Van
openaire +3 more sources
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammation of the joints in childhood. Currently, JIA is divided into 7 subtypes, distinguished on the basis of the symptoms present in the first six months of the illness. Pharmacological treatment is different for every subtype. With all forms of JIA, dental problems can occur.
Schatorjé, E.J., Royen-Kerkhof, A. Van
openaire +3 more sources
Current Opinion in Rheumatology, 2001
A significant amount of work has been performed over the past 2 years further defining the pathophysiology of juvenile idiopathic arthritis (JIA). The development of the biologic agent etanercept represents successful translational research. This genetically engineered fusion protein targets tumor necrosis factor, binding and inactivating this ...
D T, Kulas, L, Schanberg
openaire +2 more sources
A significant amount of work has been performed over the past 2 years further defining the pathophysiology of juvenile idiopathic arthritis (JIA). The development of the biologic agent etanercept represents successful translational research. This genetically engineered fusion protein targets tumor necrosis factor, binding and inactivating this ...
D T, Kulas, L, Schanberg
openaire +2 more sources

